Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia by Gätke Mona R, Bundgaard Jens R, Viby-Mogensen Jørgen in Pharmacogenetics and genomics (2007).

[PMID: 18075469] PubMed


Butyrylcholinesterase (BChE) hydrolyses the neuromuscular blocking agents, succinylcholine and mivacurium used during general anaesthesia. Hereditary low BChE activity may result in an extensively prolonged duration of action of these drugs, especially in patients who are homozygous for the atypical or silent variants. We present three novel mutations in the butyrylcholinesterase gene (BCHE) identified in three families in which a member had experienced severely prolonged duration of action of succinylcholine.

[ hide abstract ]

Discussed In Paper


Related In Paper

Rx Annotations

No dosing information annotated.